October 2022 issue
October 31, 2022 | Medtronic plc, the Minneapolis, MN manufacturer of neuromodulation systems, announced its intention to pursue a separation of the company’s patient monitoring and respiratory interventions businesses, which are part of the company’s Medical Surgical Portfolio. The as-yet unnamed spinoff will include the BIS monitoring system, which measures depth of consciousness in the operating room.
Medtronic obtained the BIS product line in its merger with Covidien in 2014. Covidien obtained the product line when it acquired developer Aspect Medical in 2009 for $210 million. The BIS monitor is derived from EEG data and has been used as a tool to reduce the risk of intraoperative awareness.
In fiscal year 2022, the combined patient monitoring and respiratory interventions businesses generated global revenue of approximately $2.2 billion.
